Description: Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Home Page: www.akoyabio.com
AKYA Technical Analysis
100 Campus Drive
Marlborough,
MA
01752
United States
Phone:
855 896 8401
Officers
| Name | Title |
|---|---|
| Mr. Brian McKelligon | Pres, CEO & Director |
| Dr. Garry P. Nolan Ph.D. | Co-Founder, Independent Director & Head of the Scientific Advisory Board |
| Mr. Joseph S. Driscoll | Chief Financial Officer |
| Dr. Frederic G. Pla Ph.D. | Chief Operating Officer |
| Dr. Nikolay Samusik Ph.D. | Co-Founder |
| Dr. Yury Goltsev Ph.D. | Co-Founder |
| Mr. Clifford C. Hoyt | VP of Translational & Scientific Affairs |
| Priyam Shah | Sr. Director of Bus. Devel. & Investor Relations Strategy |
| Mr. Paul Grass | Sr. VP of Sales |
| Ms. Marilee Moy M.B.A. | Chief People Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.2478 |
| Price-to-Sales TTM: | 6.6669 |
| IPO Date: | 2021-04-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 319 |